Uniqueness of pilsicainide in class Ic antiarrhythmics

Japanese Heart Journal

Volumn 39, Issue 3, 1998, Pages 389-397

  Yamashita, Takeshi ^a   Murakawa, Yuji ^a   Sezaki, Kazunori ^a   Hayami, Noriyuki ^a   Inoue, Masashi ^a   Fukui, Ei Ichi ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antiarrhythmics; Atrium; Electrophysiology; Pilsicainide; Potassium channel

Indexed keywords

ANTIARRHYTHMIC AGENT; PILSICAINIDE;

ANIMAL CELL; ARTICLE; HEART ATRIUM; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; MUSCLE ACTION POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RABBIT; VOLTAGE CLAMP;

EID: 0031865154     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.39.389     Document Type: Article

References (23)

1. Inomata N, Ishihara T, Akaike N. Different time course of the blockade of sodium current by lignocaine and SUN1165 in single myocytes isolated from guinea-pig atrium. Br J Pharmacol 1989; 98: 149-54.
2. Kuhara Y, Inoko M, Hatakeyama N, Momose Y, Sasayama S. Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium. J Cardiovasc Pharmacol 1996; 27: 42-51.
3. Atarashi H, Inoue H, Hiejima K, Hayakawa H, for the PSTAF Investigators. Conversion of recentonset atrial fibrillation by a single oral dose of pilsicainide (Pilsicainide suppression trial on atrial fibrillation). Am J Cardiol 1996; 78: 694-7.
4. Terazawa T, Suzuki M, Goto T, et al. Suppressive effect of SUN1165 on supraventricular tachycardia. Am Heart J 1991; 121: 1437-44.
5. Harrison DC. Antiarrhythmic drug classification: new science and practical applications. Am J Cardiol 1985; 56: 185-7.
6. Yamashita T, Nakajima T, Hamada E, Hazama. H, Omata M, Kurachi Y. Flecainide inhibits the transient outward current in atrial myocytes isolated from the rabbit heart. J Pharmacol Exp Ther 1995; 274: 315-21.
7. Ca in single frog cardiac cells by quinidine, flecainide, ethmozin, and ethacizin. Am J Physiol 1989; 257: H1773-81.
8. Follmer CH, Cullinan CA, Colatsky TJ. Differential block of cardiac delayed rectifier current by class Ic antiarrhythmic drugs: evidence for open channel block and unblock. Cardiovasc Res 1992; 26: 1121-30.
9. + current in guinea pig ventricular myocytes: voltage-independent and time-dependent block of the slowly activating component. Circ Res 1995; 76: 223-35.
10. + channel blocking action of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther 1994; 269: 66-74.
11. Delgado C, Tamargo J, Henzel D, Lorente P. Effects of propafenone on calcium current in guinea-pig ventricular myocytes. Br J Pharmacol 1993; 108: 721-7.
12. Duan D, Fermini B, Nattel S. Potassium channel blocking properties of propafenone in rabbit atrial myocytes. J Pharmacol Exp Ther 1993; 264: 1113-23.
13. Yamashita T, Nakajima T, Hamada E, Hazama H, Murakawa Y, Omata M. Regional differences in the transient outward current density and repolarization inhomogeneities in the rabbit right atrium. Circulation 1995; 92: 3061-9.
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for highresolution current recording from cells and cell free patches. Pflugers Arch 1981; 391: 85-100.
15. Giles WR, Imaizumi Y. Comparison of potassium currents in rabbit atrial and ventricular cells. J Physiol 1988; 405: 123-45.
16. Winslow E, Campbell JK. Comparative frequency-dependent effects of three class Ic agents, Org 7797, flecainide, and propafenone, on ventricular action potential duration. J Cardiovasc Pharmacol 1991; 18: 911-7.
17. Inomata N, Ohno T, Ishihara T, Akaike N. Antiarrhythmic agents act differently on the activation phase of the Ach-response in guinea-pig atrial myocytes. Br J Pharmacol 1993; 108: 111-5.
18. + channels in Xenopus oocytes. Br J Pharmacol 1992; 107: 1061-70.
19. Wu B, Sato T, Kiyosue T, Arita M. Blockade of 2, 4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs. Cardiovasc Res 1992; 26: 1095-101.
20. Task Force of the Working Group on Arrhythmia of European Society of Cardiology. The Sicilian Gambit-new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Eur Heart J 1991; 12: 1112-31.
21. Fujito T, Takayanagi K, Shimizu M, et al. Days required for 75% suppression of ventricular premature contractions by antiarrhythmic agents obtained from continuous in-hospital ECG monitoring. Jpn Heart J 1994; 35: 125-40
22. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-12.
23. Inoue M, Inoue D, Ishibashi K. et al. Effects of pilsicainide on the atrial fibrillation in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide Jpn Heart J 1993; 34: 301-12